Patents by Inventor Jingwei Lu

Jingwei Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220348629
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Application
    Filed: April 8, 2022
    Publication date: November 3, 2022
    Inventors: Jingwei LU, Zhiyuan YANG, Cheng LIU, Hong LIU, Yiyang XU, Su YAN, Vivien Wai-Fan CHAN, Lucas HORAN
  • Patent number: 11421013
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: August 23, 2022
    Assignee: EUREKA THERAPEUTICS, INC.
    Inventors: Jingwei Lu, Zhiyuan Yang, Cheng Liu, Hong Liu, Yiyang Xu, Su Yan, Vivien Wai-Fan Chan, Lucas Horan
  • Publication number: 20210253665
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Application
    Filed: February 22, 2021
    Publication date: August 19, 2021
    Inventors: Jingwei LU, Zhiyuan YANG, Cheng LIU, Hong LIU, Yiyang XU, Su YAN, Vivien Wai-Fan CHAN, Lucas HORAN
  • Patent number: 10822389
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: November 3, 2020
    Assignee: EUREKA THERAPEUTICS, INC.
    Inventors: Jingwei Lu, Zhiyuan Yang, Cheng Liu, Hong Liu, Yiyang Xu, Su Yan, Vivien Wai-Fan Chan, Lucas Horan
  • Publication number: 20200115434
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Application
    Filed: October 29, 2019
    Publication date: April 16, 2020
    Inventors: Jingwei LU, Zhiyuan YANG, Cheng LIU, Hong LIU, Yiyang XU, Su YAN, Vivien Wai-Fan CHAN, Lucas HORAN
  • Patent number: 10464988
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Grant
    Filed: September 4, 2018
    Date of Patent: November 5, 2019
    Assignee: EUREKA THERAPEUTICS, INC.
    Inventors: Jingwei Lu, Zhiyuan Yang, Cheng Liu, Hong Liu, Yiyang Xu, Su Yan, Vivien Wai-Fan Chan, Lucas Horan
  • Publication number: 20190315859
    Abstract: Described herein are human antibody agents and multi-specific binding agents that specifically bind human CD 19, in particular, native human CD 19. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by CD 19 expression, in particular, B cell lymphomas and leukemias.
    Type: Application
    Filed: April 18, 2019
    Publication date: October 17, 2019
    Inventors: HONG LIU, Jingwei Lu, Zhiyuan Yang, Li Long, Neal Cheng
  • Publication number: 20190248865
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Application
    Filed: October 21, 2016
    Publication date: August 15, 2019
    Inventors: Jingwei LU, Zhiyuan YANG, Cheng LIU, Hong LIU, Yiyang XU, Su YAN, Vivien Wai-Fan CHAN, Lucas HORAN
  • Patent number: 10301388
    Abstract: Described herein are human antibody agents and multi-specific binding agents that specifically bind human CD 19, in particular, native human CD 19. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by CD 19 expression, in particular, B cell lymphomas and leukemias.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: May 28, 2019
    Assignee: Eureka Therapeutics, Inc.
    Inventors: Hong Liu, Jingwei Lu, Zhiyuan Yang, Li Long, Neal Cheng
  • Publication number: 20190022216
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Application
    Filed: September 4, 2018
    Publication date: January 24, 2019
    Inventors: Jingwei LU, Zhiyuan YANG, Cheng LIU, Hong LIU, Yiyang XU, Su YAN, Vivien Wai-Fan CHAN, Lucas HORAN
  • Patent number: 10098951
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: October 16, 2018
    Assignee: EUREKA THERAPEUTICS, INC.
    Inventors: Jingwei Lu, Zhiyuan Yang, Cheng Liu, Hong Liu, Yiyang Xu, Su Yan, Vivien Wai-Fan Chan, Lucas Horan
  • Publication number: 20180134787
    Abstract: Described herein are human antibody agents and multi-specific binding agents that specifically bind human CD 19, in particular, native human CD 19. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by CD 19 expression, in particular, B cell lymphomas and leukemias.
    Type: Application
    Filed: December 13, 2017
    Publication date: May 17, 2018
    Inventors: HONG LIU, Jingwei Lu, Zhiyuan Yang, Li Long, Neal Cheng
  • Publication number: 20180085457
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Application
    Filed: December 1, 2017
    Publication date: March 29, 2018
    Inventors: Jingwei LU, Zhiyuan YANG, Cheng LIU, Hong LIU, Yiyang XU, Su YAN, Vivien Wai-Fan CHAN, Lucas HORAN
  • Patent number: 7853603
    Abstract: Detailed herein is a technology which, among other things, allows a search engine to utilize a user-defined relevance function. In one approach to the technology, a method of applying a user-defined relevance function is described. In this approach, a complex search query is decomposed into a simple operator. The simple operator is associated with the user-defined relevance function. A document which matches the search query is retrieved, and a rank is calculated for the document, using the user-defined relevance function.
    Type: Grant
    Filed: May 23, 2007
    Date of Patent: December 14, 2010
    Assignee: Microsoft Corporation
    Inventors: Denis Churin, Jingwei Lu, Nimish Khanolkar, Sundaram Narayanan, Tapas Nayak, Feng Tian
  • Patent number: 7509252
    Abstract: Consistency between the components used to generate and query a full-text index is determined and if a mismatch is detected, an error may be surfaced. A structure including information associated with each component used to build an index is programmatically compared with currently available components. The structure may be interrogated to enumerate the resources bound to a particular index. The enumeration of bound resources facilitates determination of what indexes (if any) must be regenerated for consistency as a result of a component upgrade or a move to another system.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: March 24, 2009
    Assignee: Microsoft Corporation
    Inventors: Andrew B. Cencini, Mihai Tudor Popescu-Stanesti, Nimish S. Khanolkar, Jingwei Lu
  • Publication number: 20080294620
    Abstract: Detailed herein is a technology which, among other things, allows a search engine to utilize a user-defined relevance function. In one approach to the technology, a method of applying a user-defined relevance function is described. In this approach, a complex search query is decomposed into a simple operator. The simple operator is associated with the user-defined relevance function. A document which matches the search query is retrieved, and a rank is calculated for the document, using the user-defined relevance function.
    Type: Application
    Filed: May 23, 2007
    Publication date: November 27, 2008
    Applicant: Microsoft Corporation
    Inventors: Denis Churin, Jingwei Lu, Nimish Khanolkar, Sundaram Narayanan, Tapas Nayak, Feng Tian
  • Publication number: 20080114750
    Abstract: The subject disclosure pertains to systems and methods for facilitating item retrieval and/or ranking. An original ranking of items can be modified and enhanced utilizing a Markov Random Field (MRF) approach based upon item similarity. Item similarity can be measured utilizing a variety of methods. An MRF similarity model can be generated by measuring of similarity between items. An original ranking of items can be obtained, where each document is evaluated independently based upon a query. For example, the original ranking can be obtained using a keyword search. The original ranking can be enhanced based upon similarity of items. For example, items that are deemed to be similar should have similar rankings. The MRF model can be used in conjunction with original rankings to adjust rankings to reflect item relationships.
    Type: Application
    Filed: November 14, 2006
    Publication date: May 15, 2008
    Applicant: MICROSOFT CORPORATION
    Inventors: Ashutosh Saxena, Jingwei Lu, Nimish Khanolkar
  • Publication number: 20050137856
    Abstract: Consistency between the components used to generate and query a full-text index is determined and if a mismatch is detected, an error may be surfaced. A structure including information associated with each component used to build an index is programmatically compared with currently available components. The structure may be interrogated to enumerate the resources bound to a particular index. The enumeration of bound resources facilitates determination of what indexes (if any) must be regenerated for consistency as a result of a component upgrade or a move to another system.
    Type: Application
    Filed: December 22, 2003
    Publication date: June 23, 2005
    Inventors: Andrew Cencini, Mihai Popescu-Stanesti, Nimish Khanolkar, Jingwei Lu